Koers HedgePath Pharmaceuticals Inc
Aandelen
US42278K1025
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13-12-22 |
Amy M. McCord
LAW | General Counsel | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02-08-13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,37% | 48,16 mld. | |
-1,01% | 41,73 mld. | |
+43,91% | 41,03 mld. | |
-5,31% | 28,77 mld. | |
+9,34% | 25,59 mld. | |
-21,69% | 18,96 mld. | |
+6,23% | 12,92 mld. | |
+26,99% | 12,03 mld. | |
-3,38% | 11,77 mld. |